A Senate committee today shined the spotlight on the wave of high and unexpected increases in prescription drug costs that puts an incredible financial strain on hospitals and health systems and threaten our ability to provide high quality care each and every day.

In a statement submitted to the committee’s hearing on drug prices, the AHA recommended Congress and the administration move quickly to take a number of steps that would increase competition, transparency, access and value, while fostering innovation.

The impact of skyrocketing drug prices goes far beyond hospitals’ and health systems’ budgets. Everyone eventually feels it, including patients, insurance companies, employers, the government and taxpayers. All of us. Even those who are healthy and medication-free pay more when drug prices outpace inflation through increased premiums, co-pays, deductibles and taxes. When drug companies put profits before patients, we all pay the price.

The women and men who work in America’s hospitals and health systems recognize the value of truly innovative, life-saving medicines as much as anyone. But a drug priced beyond our reach or a patient’s reach will not save anyone’s life.

Related News Articles

Headline
About 34 percent of uninsured U.S. adults did not take their medication as prescribed in 2017 in order to reduce their prescription drug costs, according to a…
Headline
Legislative proposals for a Medicare public option could negatively affect patient access to care and significantly reduce payments to hospitals, AHA Executive…
Headline
The Centers for Medicare & Medicaid Services today updated its Medicare and Medicaid drug spending dashboards with 2017 data.
Headline
The House Energy and Commerce Health Subcommittee today held a hearing to discuss seven bills aimed at increasing competition in the prescription drug market…
Headline
The Senate Special Committee on Aging today concluded a two-part hearing on the impact of rising prescription drug costs on seniors and potential policy…
Headline
Eight in 10 U.S. adults say prescription drug costs are “unreasonable,” and one in four say their prescription medicines are difficult to afford, according to…